While SNPs (excluding some located in the HLA region) individually confer small effects (odds ratio [OR] <1.6) on HL risk they have given novel insights into HL biology implicating perturbation of the Rel/NF-κB pathways in disease aetiology. The gene discussed is NFKB1; the disease is Hodgkins lymphoma.